Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Browse by collection
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Browse by collection
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 93, Issue 4
Intravitreal bevacizumab (Avastin®) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Original Article
Intravitreal bevacizumab (Avastin®) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial
Free
Online download statistics by month:
Online download statistics by month: December 2008 to March 2024
Abstract
Full
Pdf
Dec 2008
70
0
44
Jan 2009
52
0
111
Feb 2009
24
0
83
Mar 2009
116
230
176
Apr 2009
154
656
307
May 2009
108
231
211
Jun 2009
95
160
157
Jul 2009
83
129
126
Aug 2009
79
125
121
Sep 2009
106
98
136
Oct 2009
169
114
123
Nov 2009
58
75
62
Dec 2009
28
62
42
Jan 2010
27
52
52
Feb 2010
27
33
66
Mar 2010
19
40
28
Apr 2010
25
61
45
May 2010
22
58
48
Jun 2010
27
45
28
Jul 2010
23
72
43
Aug 2010
33
53
42
Sep 2010
24
69
61
Oct 2010
41
89
36
Nov 2010
11
64
23
Dec 2010
14
59
26
Jan 2011
20
65
36
Feb 2011
17
64
26
Mar 2011
20
68
19
Apr 2011
17
52
17
May 2011
32
72
55
Jun 2011
20
41
25
Jul 2011
19
32
34
Aug 2011
26
68
41
Sep 2011
21
53
40
Oct 2011
24
49
36
Nov 2011
43
2620
988
Dec 2011
127
110
48
Jan 2012
57
98
28
Feb 2012
34
55
19
Mar 2012
26
72
30
Apr 2012
39
82
38
May 2012
37
60
21
Jun 2012
73
35
19
Jul 2012
40
44
19
Aug 2012
34
23
16
Sep 2012
44
22
16
Oct 2012
50
87
20
Nov 2012
78
73
22
Dec 2012
57
17
13
Jan 2013
77
42
38
Feb 2013
29
37
7
Mar 2013
35
29
11
Apr 2013
48
30
22
May 2013
41
46
13
Jun 2013
39
30
13
Jul 2013
30
10
13
Aug 2013
35
12
13
Sep 2013
34
14
16
Oct 2013
44
38
17
Nov 2013
31
33
10
Dec 2013
33
26
17
Jan 2014
41
10
16
Feb 2014
33
10
7
Mar 2014
64
24
28
Apr 2014
33
20
14
May 2014
23
10
10
Jun 2014
26
6
9
Jul 2014
49
14
12
Aug 2014
34
8
10
Sep 2014
26
14
5
Oct 2014
43
7
12
Nov 2014
52
13
19
Dec 2014
31
4
4
Jan 2015
35
5
11
Feb 2015
26
9
12
Mar 2015
48
4
10
Apr 2015
25
9
14
May 2015
43
11
11
Jun 2015
28
3
20
Jul 2015
28
7
12
Aug 2015
25
7
6
Sep 2015
31
5
10
Oct 2015
21
2
5
Nov 2015
33
9
3
Dec 2015
38
12
11
Jan 2016
46
5
13
Feb 2016
23
4
2
Mar 2016
22
12
12
Apr 2016
25
5
10
May 2016
31
6
5
Jun 2016
29
6
4
Jul 2016
17
4
9
Aug 2016
20
6
11
Sep 2016
27
7
11
Oct 2016
22
6
8
Nov 2016
36
4
13
Dec 2016
19
9
10
Jan 2017
25
3
3
Feb 2017
9
5
20
Mar 2017
14
12
13
Apr 2017
10
7
1
May 2017
18
22
8
Jun 2017
15
8
2
Jul 2017
26
12
4
Aug 2017
43
13
13
Sep 2017
105
85
8
Oct 2017
213
188
8
Nov 2017
90
70
8
Dec 2017
120
100
2
Jan 2018
98
76
3
Feb 2018
151
105
2
Mar 2018
105
75
4
Apr 2018
120
80
4
May 2018
105
71
8
Jun 2018
123
91
13
Jul 2018
171
131
2
Aug 2018
166
124
8
Sep 2018
125
117
0
Oct 2018
83
65
2
Nov 2018
96
68
17
Dec 2018
87
79
1
Jan 2019
74
65
2
Feb 2019
72
64
12
Mar 2019
38
12
9
Apr 2019
25
9
7
May 2019
38
28
7
Jun 2019
92
84
16
Jul 2019
71
61
8
Aug 2019
83
73
13
Sep 2019
102
76
7
Oct 2019
74
68
7
Nov 2019
62
59
0
Dec 2019
84
79
1
Jan 2020
84
78
2
Feb 2020
76
68
5
Mar 2020
82
72
7
Apr 2020
82
78
4
May 2020
95
93
5
Jun 2020
67
65
9
Jul 2020
75
63
13
Aug 2020
57
53
3
Sep 2020
91
83
4
Oct 2020
86
74
5
Nov 2020
24
15
6
Dec 2020
84
59
11
Jan 2021
35
22
7
Feb 2021
13
5
5
Mar 2021
17
7
10
Apr 2021
22
16
13
May 2021
6
4
5
Jun 2021
11
9
8
Jul 2021
11
11
11
Aug 2021
22
19
7
Sep 2021
10
10
18
Oct 2021
21
9
22
Nov 2021
22
8
15
Dec 2021
25
15
4
Jan 2022
17
12
1
Feb 2022
17
14
4
Mar 2022
16
11
6
Apr 2022
32
22
15
May 2022
28
23
8
Jun 2022
35
26
5
Jul 2022
12
12
4
Aug 2022
36
25
5
Sep 2022
43
28
12
Oct 2022
30
21
8
Nov 2022
24
15
7
Dec 2022
30
19
10
Jan 2023
41
26
15
Feb 2023
18
10
3
Mar 2023
18
12
4
Apr 2023
25
15
13
May 2023
22
18
6
Jun 2023
16
8
2
Jul 2023
19
8
8
Aug 2023
21
5
14
Sep 2023
33
16
5
Oct 2023
43
24
8
Nov 2023
46
14
10
Dec 2023
32
32
9
Jan 2024
28
15
11
Feb 2024
22
11
9
Mar 2024
11
6
32
Total
8785
10850
5068
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF